Document is current
Any future updates will be listed below
-
Authors
Gauthier, Thierry
Martin-Rodriguez, Omayra
Chagué, Cécile
Daoui, Anna
Ceroi, Adam
Varin, Alexis
Bonnefoy, Francis
Valmary-Degano, Séverine
Couturier, Mélanie
Behlke, Susanne
Saas, Philippe
Cartron, Pierre-François
Perruche, Sylvain
-
Funding
Funding for this research was provided by:
Etablissement Français du Sang (Fellowship, 2016-02)
Conseil régional de Bourgogne-Franche-Comté (Soutien au LabEX LipSTIC)
Ministère de l’Education Nationale, de l’Enseignement Supérieur et de la Recherche (Doctoral fellowship)
Agence Nationale de la Recherche (ANR-11-LABX-0021)
- License Information
-
More Information
Article History
Received: 24 May 2023
Accepted: 12 December 2023
First Online: 20 December 2023
Declarations
:
: Animal experimentations (#02831) were approved by the local Animal Ethics Committee of Besançon (<i>Comité d’Ethique Bisontin en Experimentation Animale</i> #58), the French Ministry of Higher Education, Research and Innovation (<i>Ministère de l’Enseignement Supérieur, de la Recherche et de l’Innovation</i>) and the French Ministry of Agriculture (experimentation protocols are registered in APAFIS system under the number 2021-004-OA-12PR). All experiments were conducted in accordance with the European Union’s Directive 2010/63.
: Not applicable.
: SP, MC, FB are founders and shareholders of MED’INN’Pharma and are inventors on patents related to the use of pharmaceutical preparations from pro-resolving macrophages. PS is shareholder and SB an employee of MED’INN’Pharma. All other authors declare no competing financial interest.
